{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:01Z","timestamp":1781636161214,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"crossref","award":["98-3-14-16153"],"award-info":[{"award-number":["98-3-14-16153"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunotherapy is a promising cancer treatment, but its effectiveness is limited by the lack of specific strategies to target cancer stem cells (CSCs). CSCs a rare tumor cell subpopulation, are thought to drive tumor recurrence, metastasis, and therapy resistance and developing targeting CSCs is needed. This study investigates the efficacy of a CSC-based vaccine in preventing and treating breast tumor growth and metastasis in a mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>4T1-CSC was enriched by sphere formation and characterized by high expression of stemness genes using real-time PCR and higher in vivo tumorigenicity compared to parental cells. Whole CSC lysates were used as vaccine in prophylactic and therapeutic settings and their efficacy was compared with parental cells, normal saline and adjuvant-injected groups in terms of tumor growth, liver and lungs metastasis and survival. Additionally, the presence of antibodies against CSCs and parental cells was evaluated by flow cytometry and immunofluorescence staining in vaccinated mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CSC enrichment was confirmed by higher stemness gene expression and tumorigenicity in spheroid cells. CSC-Prophylactic vaccination significantly reduced tumor growth, lung and liver metastasis and improved survival compared to parental cell and control groups. Therapeutic vaccination reduced tumor growth until day 15, increases in survival and decreases in metastasis. Both vaccinations showed that CSC-vaccinated mice sera reacted more intensely with parental cells than with spheroid cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CSC-based immunizations significantly reduce tumor growth and metastasis, enhancing survival. These findings underscore the potential of CSC-targeted therapies in cancer treatment, necessitating further research to develop effective breast cancer treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02242-7","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:53:38Z","timestamp":1771498418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic and therapeutic CSC-based vaccination reduced tumor growth, metastasis and enhanced survival in mouse model of breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Masoumeh","family":"Dehghan Manshadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Safaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannaneh","family":"Golshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Bozorgmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Eini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Bolouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Madjd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Ghods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2242_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"issue":"5","key":"2242_CR2","first-page":"311","volume":"9","author":"OJ Scully","year":"2012","unstructured":"Scully OJ, Bay B-H, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteomics. 2012;9(5):311\u201320.","journal-title":"Cancer Genom Proteom"},{"issue":"12","key":"2242_CR3","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/cells8121492","volume":"8","author":"L Ding","year":"2019","unstructured":"Ding L, Gu H, Xiong X, Ao H, Cao J, Lin W, et al. MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer. Cells. 2019;8(12):1492.","journal-title":"Cells"},{"issue":"7","key":"2242_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41416-021-01413-x","volume":"125","author":"C Pilard","year":"2021","unstructured":"Pilard C, Ancion M, Delvenne P, Jerusalem G, Hubert P, Herfs M. Cancer immunotherapy: it\u2019s time to better predict patients\u2019 response. Br J Cancer. 2021;125(7):927\u201338.","journal-title":"Br J Cancer"},{"key":"2242_CR5","doi-asserted-by":"crossref","unstructured":"Ghadially R, Kim RW, Charruyer-Reinwald A. Cancer stem cells and their role in metastasis. Cancer metastasis through the lymphovascular system. Springer; 2022. pp. 749\u201356.","DOI":"10.1007\/978-3-030-93084-4_71"},{"issue":"2","key":"2242_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pharmthera.2013.01.014","volume":"138","author":"Y Shiozawa","year":"2013","unstructured":"Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS. Cancer stem cells and their role in metastasis. Pharmacol Ther. 2013;138(2):285\u201393.","journal-title":"Pharmacol Ther"},{"key":"2242_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gene.2018.09.052","volume":"681","author":"A Ku\u015fo\u011flu","year":"2019","unstructured":"Ku\u015fo\u011flu A, Avc\u0131 \u00c7B. Cancer stem cells: a brief review of the current status. Gene. 2019;681:80\u20135.","journal-title":"Gene"},{"issue":"1","key":"2242_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","volume":"6","author":"H-M Zhou","year":"2021","unstructured":"Zhou H-M, Zhang J-G, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Therapy. 2021;6(1):62.","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"2242_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/imt.10.10","volume":"2","author":"Y Hirohashi","year":"2010","unstructured":"Hirohashi Y, Torigoe T, Inoda S, Takahashi A, Morita R, Nishizawa S, et al. Immune response against tumor antigens expressed on human cancer stem-like cells\/tumor-initiating cells. Immunotherapy. 2010;2(2):201\u201311.","journal-title":"Immunotherapy"},{"issue":"9","key":"2242_CR10","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/stem.1163","volume":"30","author":"F Francescangeli","year":"2012","unstructured":"Francescangeli F, Patrizii M, Signore M, Federici G, Di Franco S, Pagliuca A, et al. Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells. Stem Cells. 2012;30(9):1819\u201330.","journal-title":"Stem Cells"},{"issue":"8","key":"2242_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4161\/onci.21026","volume":"1","author":"S Teitz-Tennenbaum","year":"2012","unstructured":"Teitz-Tennenbaum S, Wicha MS, Chang AE, Li Q. Targeting cancer stem cells via dendritic-cell vaccination. Oncoimmunology. 2012;1(8):1401\u20133.","journal-title":"Oncoimmunology"},{"issue":"7","key":"2242_CR12","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1111\/jcmm.16401","volume":"25","author":"M Naseri","year":"2021","unstructured":"Naseri M, Z\u00f6ller M, Hadjati J, Ghods R, Ranaei Pirmardan E, Kiani J, et al. Dendritic cells loaded with exosomes derived from cancer stem cell-enriched spheroids as a potential immunotherapeutic option. J Cell Mol Med. 2021;25(7):3312\u201326.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2242_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009;138(2):286\u201399.","journal-title":"Cell"},{"issue":"13","key":"2242_CR14","doi-asserted-by":"publisher","first-page":"16479","DOI":"10.18632\/oncotarget.7660","volume":"7","author":"SY Yoo","year":"2016","unstructured":"Yoo SY, Bang SY, Jeong S-N, Kang DH, Heo J. A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer. Oncotarget. 2016;7(13):16479.","journal-title":"Oncotarget"},{"issue":"6","key":"2242_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s13238-017-0394-6","volume":"9","author":"Y Guo","year":"2018","unstructured":"Guo Y, Feng K, Wang Y, Han W. Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment. Protein Cell. 2018;9(6):516\u201326.","journal-title":"Protein Cell"},{"key":"2242_CR16","doi-asserted-by":"publisher","first-page":"569017","DOI":"10.3389\/fonc.2020.569017","volume":"10","author":"S Forster","year":"2020","unstructured":"Forster S, Radpour R. Molecular immunotherapy: promising approach to treat metastatic colorectal cancer by targeting resistant cancer cells or cancer stem cells. Front Oncol. 2020;10:569017.","journal-title":"Front Oncol"},{"issue":"7","key":"2242_CR17","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1158\/0008-5472.CAN-11-1400","volume":"72","author":"N Ning","year":"2012","unstructured":"Ning N, Pan Q, Zheng F, Teitz-Tennenbaum S, Egenti M, Yet J, et al. Cancer stem cell vaccination confers significant antitumor immunity. Cancer Res. 2012;72(7):1853\u201364.","journal-title":"Cancer Res"},{"issue":"3","key":"2242_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/stmcls\/sxac089","volume":"41","author":"F Hashemi","year":"2023","unstructured":"Hashemi F, Razmi M, Tajik F, Z\u00f6ller M, Dehghan Manshadi M, Mahdavinezhad F, et al. Efficacy of whole cancer stem cell-based vaccines: a systematic review of preclinical and clinical studies. Stem Cells. 2023;41(3):207\u201332.","journal-title":"Stem Cells"},{"key":"2242_CR19","doi-asserted-by":"crossref","unstructured":"Wu D, Yu X, Wang J, Hui X, Zhang Y, Cai Y et al. Ovarian cancer stem cells with high ROR1 expression serve as a new prophylactic vaccine for ovarian cancer. J Immunol Res. 2019;2019.","DOI":"10.1155\/2019\/9394615"},{"issue":"4","key":"2242_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/cgt.2016.80","volume":"24","author":"C Sakamoto","year":"2017","unstructured":"Sakamoto C, Kohara H, Inoue H, Narusawa M, Ogawa Y, Hirose-Yotsuya L, et al. Therapeutic vaccination based on side population cells transduced by the granulocyte\u2013macrophage colony-stimulating factor gene elicits potent antitumor immunity. Cancer Gene Ther. 2017;24(4):165\u201374.","journal-title":"Cancer Gene Ther"},{"key":"2242_CR21","doi-asserted-by":"crossref","unstructured":"Singh SP, Singh R, Gupta OP, Gupta S, Brahma Bhatt ML. Immunotherapy: newer therapeutic armamentarium against cancer stem cells. J Oncol. 2020;2020.","DOI":"10.1155\/2020\/3963561"},{"issue":"3","key":"2242_CR22","doi-asserted-by":"publisher","first-page":"e990767","DOI":"10.4161\/2162402X.2014.990767","volume":"4","author":"L Lu","year":"2015","unstructured":"Lu L, Tao H, Chang AE, Hu Y, Shu G, Chen Q, et al. Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells. Oncoimmunology. 2015;4(3):e990767.","journal-title":"Oncoimmunology"},{"issue":"3","key":"2242_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/stem.1292","volume":"31","author":"S Duarte","year":"2013","unstructured":"Duarte S, Momier D, Baqu\u00e9 P, Casanova V, Loubat A, Samson M, et al. Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model. Stem Cells. 2013;31(3):423\u201332.","journal-title":"Stem Cells"},{"issue":"7","key":"2242_CR24","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1007\/s00432-022-04303-8","volume":"149","author":"L Eini","year":"2023","unstructured":"Eini L, Naseri M, Karimi-Busheri F, Bozorgmehr M, Ghods R, Madjd Z. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model. J Cancer Res Clin Oncol. 2023;149(7):4101\u201316.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1\u20132","key":"2242_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cellimm.2013.07.018","volume":"284","author":"X Liu","year":"2013","unstructured":"Liu X, Hu J, Cao W, Qu H, Wang Y, Ma Z, Li F. Effects of two different immunotherapies on triple negative breast cancer in animal model. Cell Immunol. 2013;284(1\u20132):111\u20138.","journal-title":"Cell Immunol"},{"key":"2242_CR26","doi-asserted-by":"publisher","first-page":"106850","DOI":"10.1016\/j.intimp.2020.106850","volume":"88","author":"M Guo","year":"2020","unstructured":"Guo M, Luo B, Pan M, Li M, Xu H, Zhao F, Dou J. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer. Int Immunopharmacol. 2020;88:106850.","journal-title":"Int Immunopharmacol"},{"key":"2242_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10928-020-09673-5","volume":"47","author":"L Yang","year":"2020","unstructured":"Yang L, Yong L, Zhu X, Feng Y, Fu Y, Kong D, et al. Disease progression model of 4T1 metastatic breast cancer. J Pharmacokinet Pharmacodyn. 2020;47:105\u201316.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"2242_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21315\/mjms2022.29.3.4","volume":"29","author":"H Rajaratinam","year":"2022","unstructured":"Rajaratinam H, Rasudin NS, Safuan S, Abdullah NA, Mokhtar NF, Fuad WEM. Passage number of 4T1 cells influences the development of tumour and the progression of metastasis in 4T1 orthotopic mice. Malays J Med Sci MJMS. 2022;29(3):30.","journal-title":"Malays J Med Sci MJMS"},{"key":"2242_CR29","doi-asserted-by":"crossref","unstructured":"Anand S, Yasinchak A, Bullock T, Govande M, Maytin EV. A non-toxic approach for treatment of breast cancer and its metastases: capecitabine enhanced photodynamic therapy in a murine breast tumor model. J Cancer Metastasis Treat. 2019;5.","DOI":"10.20517\/2394-4722.2018.98"},{"key":"2242_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-01898-9","volume":"21","author":"E Gheytanchi","year":"2021","unstructured":"Gheytanchi E, Naseri M, Karimi-Busheri F, Atyabi F, Mirsharif ES, Bozorgmehr M, et al. Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines. Cancer Cell Int. 2021;21:1\u201316.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2242_CR31","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/jcp.29150","volume":"235","author":"L Eini","year":"2020","unstructured":"Eini L, Naseri M, Karimi-Busheri F, Bozorgmehr M, Ghods R, Madjd Z. Primary colonospheres maintain stem cell\u2010like key features after cryopreservation. J Cell Physiol. 2020;235(3):2452\u201363.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2242_CR32","first-page":"585","volume":"17","author":"A Volarevic","year":"2012","unstructured":"Volarevic A, Ljujic B, Volarevic V, Milovanovic M, Kanjevac T, Lukic A, Arsenijevic N. A new semiquantitative method for evaluation of metastasis progression. J BUON. 2012;17(3):585\u201390.","journal-title":"J BUON"},{"issue":"1","key":"2242_CR33","doi-asserted-by":"publisher","first-page":"17333","DOI":"10.1038\/s41598-019-53911-x","volume":"9","author":"D Sikpa","year":"2019","unstructured":"Sikpa D, Fouquet JP, Lebel R, Diamandis P, Richer M, Lepage M. Automated detection and quantification of breast cancer brain metastases in an animal model using democratized machine learning tools. Sci Rep. 2019;9(1):17333.","journal-title":"Sci Rep"},{"key":"2242_CR34","doi-asserted-by":"crossref","unstructured":"Safaei S, Dehghan Manshadi M, Golshahi H, Hashemi F, Sasani F, Madjd Z, Ghods R. Placenta specific 1: a novel marker for detection of metastasis in mouse model of breast cancer. Biomarkers. 2025(just-accepted):1\u201320.","DOI":"10.1080\/1354750X.2025.2556166"},{"issue":"1","key":"2242_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.32471\/exp-oncology.2312-8852.vol-41-no-1.12743","volume":"41","author":"J Mahmoudian","year":"2019","unstructured":"Mahmoudian J, Ghods R, Nazari M, Jeddi-Tehrani M, Ghahremani M, Ostad S, Zarnani A. Expression profiling of plac1 in murine cancer cell lines. Exp Oncol. 2019;41(1):7\u201313.","journal-title":"Exp Oncol"},{"key":"2242_CR36","doi-asserted-by":"publisher","first-page":"115682","DOI":"10.1016\/j.ab.2024.115682","volume":"696","author":"S Mortezagholi","year":"2025","unstructured":"Mortezagholi S, Maghsood F, Shojaeian S, Shokri F, Amiri MM, Ghorbani A, et al. Production and characterization of a panel of anti-mouse placenta-specific protein 1 (plac1) monoclonal antibodies. Anal Biochem. 2025;696:115682.","journal-title":"Anal Biochem"},{"issue":"4260","key":"2242_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell PC. The clonal evolution of tumor cell populations: acquired genetic lability permits Stepwise selection of variant sublines and underlies tumor progression. Science. 1976;194(4260):23\u20138.","journal-title":"Science"},{"issue":"6","key":"2242_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10(6):717\u201328.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2242_CR39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730\u20137.","journal-title":"Nat Med"},{"key":"2242_CR40","doi-asserted-by":"crossref","unstructured":"Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A, editors. Cancer stem cells: the root of tumor recurrence and metastases. Seminars in cancer biology. Elsevier; 2017.","DOI":"10.1016\/j.semcancer.2017.02.011"},{"key":"2242_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bioactmat.2022.10.016","volume":"22","author":"X Zhang","year":"2023","unstructured":"Zhang X, Cui H, Zhang W, Li Z, Gao J. Engineered tumor cell-derived vaccines against cancer: the art of combating poison with poison. Bioactive Mater. 2023;22:491\u2013517.","journal-title":"Bioactive Mater"},{"issue":"12","key":"2242_CR42","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/vaccines9121490","volume":"9","author":"M Ghattas","year":"2021","unstructured":"Ghattas M, Dwivedi G, Lavertu M, Alameh M-G. Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities. Vaccines. 2021;9(12):1490.","journal-title":"Vaccines"},{"issue":"1","key":"2242_CR43","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C. Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Therapy. 2023;8(1):450.","journal-title":"Signal Transduct Target Therapy"},{"key":"2242_CR44","doi-asserted-by":"crossref","unstructured":"Maeng HM, Berzofsky JA. Strategies for developing and optimizing cancer vaccines. F1000Research. 2019;8.","DOI":"10.12688\/f1000research.18693.1"},{"issue":"8","key":"2242_CR45","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","volume":"22","author":"KF Bol","year":"2016","unstructured":"Bol KF, Schreibelt G, Gerritsen WR, De Vries IJM, Figdor CG. Dendritic cell-based immunotherapy: state of the art and beyond. Clin Cancer Res. 2016;22(8):1897\u2013906.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2242_CR46","first-page":"9394615","volume":"2019","author":"D Wu","year":"2019","unstructured":"Wu D, Yu X, Wang J, Hui X, Zhang Y, Cai Y, et al. Ovarian cancer stem cells with high ROR1 expression serve as a new prophylactic vaccine for ovarian cancer. J Immunol Res. 2019;2019(1):9394615.","journal-title":"J Immunol Res"},{"key":"2242_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-11-107","volume":"11","author":"X Wang","year":"2014","unstructured":"Wang X, Baddoo MC, Yin Q. The placental specific gene, PLAC1, is induced by the Epstein\u2013Barr virus and is expressed in human tumor cells. Virol J. 2014;11:1\u201310.","journal-title":"Virol J"},{"issue":"6","key":"2242_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/pd.2506","volume":"30","author":"M Fant","year":"2010","unstructured":"Fant M, Farina A, Nagaraja R, Schlessinger D. PLAC1 (Placenta-specific 1): a novel, X\u2010linked gene with roles in reproductive and cancer biology. Prenat Diagn. 2010;30(6):497\u2013502.","journal-title":"Prenat Diagn"},{"key":"2242_CR49","doi-asserted-by":"publisher","first-page":"145072","DOI":"10.1016\/j.gene.2020.145072","volume":"763","author":"Y Ren","year":"2020","unstructured":"Ren Y, Lv Y, Li T, Jiang Q. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: a study based on TCGA data. Gene. 2020;763:145072.","journal-title":"Gene"},{"issue":"1","key":"2242_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Therapy. 2020;5(1):28.","journal-title":"Signal Transduct Target Therapy"},{"key":"2242_CR51","first-page":"86","volume":"175","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tao A. Antigenicity, immunogenicity, allergenicity. Allergy Bioinf. 2015;175:86.","journal-title":"Allergy Bioinf"},{"issue":"2","key":"2242_CR52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1158\/0008-5472.CAN-09-1592","volume":"70","author":"T Schatton","year":"2010","unstructured":"Schatton T, Sch\u00fctte U, Frank NY, Zhan Q, Hoerning A, Robles SC, et al. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res. 2010;70(2):697\u2013708.","journal-title":"Cancer Res"},{"issue":"3","key":"2242_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","volume":"16","author":"T Di Tomaso","year":"2010","unstructured":"Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res. 2010;16(3):800\u201313.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2242_CR54","first-page":"1113","volume":"12","author":"A Wu","year":"2010","unstructured":"Wu A, Wei J, Kong L-Y, Wang Y, Priebe W, Qiao W, et al. Glioma cancer stem cells induce immunosuppressive macrophages\/microglia. Neurooncology. 2010;12(11):1113\u201325.","journal-title":"Neurooncology"},{"issue":"4","key":"2242_CR55","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","volume":"1","author":"M Todaro","year":"2007","unstructured":"Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 2007;1(4):389\u2013402.","journal-title":"Cell Stem Cell"},{"issue":"29","key":"2242_CR56","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1038\/onc.2014.317","volume":"34","author":"N Erin","year":"2015","unstructured":"Erin N, Podnos A, Tanriover G, Duymu\u015f \u00d6, Cote E, Khatri I, Gorczynski R. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response. Oncogene. 2015;34(29):3860\u201370.","journal-title":"Oncogene"},{"issue":"10","key":"2242_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.it.2008.07.005","volume":"29","author":"BT Kawasaki","year":"2008","unstructured":"Kawasaki BT, Farrar WL. Cancer stem cells, CD200 and immunoevasion. Trends Immunol. 2008;29(10):464\u20138.","journal-title":"Trends Immunol"},{"issue":"1","key":"2242_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/0974-777X.77299","volume":"3","author":"AS Clem","year":"2011","unstructured":"Clem AS. Fundamentals of vaccine immunology. J Global Infect Dis. 2011;3(1):73\u20138.","journal-title":"J Global Infect Dis"},{"issue":"3","key":"2242_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1158\/0008-5472.CAN-07-0445","volume":"68","author":"M de la Luz Garcia-Hernandez","year":"2008","unstructured":"de la Luz Garcia-Hernandez M, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res. 2008;68(3):861\u20139.","journal-title":"Cancer Res"},{"issue":"8","key":"2242_CR60","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/stem.102","volume":"27","author":"Q Xu","year":"2009","unstructured":"Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, et al. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells. 2009;27(8):1734\u201340.","journal-title":"Stem Cells"},{"issue":"36","key":"2242_CR61","doi-asserted-by":"publisher","first-page":"eaaw2004","DOI":"10.1126\/sciimmunol.aaw2004","volume":"4","author":"AG Snyder","year":"2019","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019;4(36):eaaw2004.","journal-title":"Sci Immunol"},{"key":"2242_CR62","doi-asserted-by":"crossref","unstructured":"Chen D, Yu J, Zhang L. Necroptosis: an alternative cell death program defending against cancer. Biochimica et biophysica acta (BBA)-Reviews on cancer. 2016;1865(2):228\u201336.","DOI":"10.1016\/j.bbcan.2016.03.003"},{"key":"2242_CR63","doi-asserted-by":"publisher","first-page":"737129","DOI":"10.3389\/fphar.2021.737129","volume":"12","author":"L Wang","year":"2021","unstructured":"Wang L, Zhou L, Zhou Y, Liu L, Jiang W, Zhang H, Liu H. Necroptosis in pulmonary diseases: a new therapeutic target. Front Pharmacol. 2021;12:737129.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2242_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12672-024-01121-x","volume":"15","author":"P Farhangnia","year":"2024","unstructured":"Farhangnia P, Ghods R, Falak R, Zarnani A-H, Delbandi A-A. Identification of placenta-specific protein 1 (PLAC-1) expression on human PC-3 cell line-derived prostate cancer stem cells compared to the tumor parental cells. Discover Oncol. 2024;15(1):251.","journal-title":"Discover Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02242-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:29:10Z","timestamp":1781634550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02242-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2242"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02242-7","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Iran University of Medical Sciences Human Research Ethics Committee approved this study (Ref No: IR.IUMS.REC. 1398.953). All procedures used in this study were in accordance with the ethical standards of the institution where it was carried out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}